期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 123, 期 7, 页码 1222-1236出版社
WILEY
DOI: 10.1002/jcb.30279
关键词
colon cancer; EMT; fangchinoline; metastasis; TGF-beta
资金
- National Research Foundation of Korea [NRF-2021R1I1A2060024, NRF-2022R1I1A1A01071593]
This study demonstrates that Fangchinoline (FCN) can inhibit the epithelial-mesenchymal transition (EMT) in human colon cancer cells, thereby reducing their metastatic and invasive capacities. In addition, FCN can suppress multiple cell signaling pathways, including c-Met/PI3K/Akt/mTOR and Wnt/β-catenin pathways. Therefore, FCN has the potential to be a novel antimetastatic agent against colon cancer.
Epithelial-mesenchymal transition (EMT) is a key process, which can promote the transition of tumor cells into other organs by weakening the cell-cell junctions. Tumor cell invasion and metastasis arising because of EMT can determine the prognosis of cancer. EMT can be induced by several growth factors including transforming growth factor-beta (TGF-beta), which can exert their effects by affecting several cell-signaling pathways. Fangchinoline (FCN), a kind of bisbenzylisoquinoline, belongs to the family Menispermaceae. FCN can display substantial antitumor effects against various malignant cell lines but its possible impact on EMT has not been explored. We examined the potential impact of FCN in affecting the activation of EMT in human colon cancer cells. We evaluated the influence of FCN on EMT in colon cancer cells by using Western blot analysis and reverse transcription-polymerase chain reaction assays. The cellular invasion and migration were observed by Boyden chamber and wound healing assays. Thereafter, the effect of the drug on proliferation and invasion was also evaluated by real-time cell analysis. FCN suppressed the levels of TGF-beta-induced mesenchymal markers, such as fibronectin, vimentin, MMP-9, MMP-2, N-cadherin, Twist, and Snail. However, FCN markedly enhanced the expression of epithelial markers such as occludin and E-cadherin. These results imply that FCN can potentially inhibit tumor metastasis through abrogating EMT. In addition, FCN downregulated c-Met/PI3K/Akt/mTOR and Wnt/beta-catenin cell signaling pathways and mitigated tumor migration as well as invasion. Overall, our study suggests a potential novel role of FCN as an antimetastatic agent against human colon cancer cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据